Liver impairment in the obese
- PMID: 13524568
Liver impairment in the obese
Similar articles
-
Survival benefit of kidney and liver transplantation for obese patients on the waiting list.Clin Transpl. 2003:77-88. Clin Transpl. 2003. PMID: 15387099 Review.
-
Impaired liver functions in the obese.Bull Moore White Med Found Los Angel. 1954 Sep;5(2):53-6. Bull Moore White Med Found Los Angel. 1954. PMID: 13199479 No abstract available.
-
Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes.J Diabetes Complications. 2007 May-Jun;21(3):149-57. doi: 10.1016/j.jdiacomp.2005.12.003. J Diabetes Complications. 2007. PMID: 17493547
-
[Liver disease in obese patients].Rev Med Suisse. 2007 Sep 5;3(123):1939-41. Rev Med Suisse. 2007. PMID: 17918488 Review. French.
-
Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of Fatty liver inflammation in obese mice.Gastroenterology. 2008 May;134(5):1459-69. doi: 10.1053/j.gastro.2008.02.055. Epub 2008 Mar 4. Gastroenterology. 2008. PMID: 18471520
Cited by
-
Fatty liver induced in Zucker "fatty" (ff) rats by a semisynthetic diet rich in sucrose.Proc Natl Acad Sci U S A. 1977 Jul;74(7):3038-42. doi: 10.1073/pnas.74.7.3038. Proc Natl Acad Sci U S A. 1977. PMID: 268652 Free PMC article.
-
Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?J Clin Transl Hepatol. 2021 Dec 28;9(6):931-938. doi: 10.14218/JCTH.2021.00174. Epub 2021 Aug 24. J Clin Transl Hepatol. 2021. PMID: 34966656 Free PMC article. Review.
-
From the origin of NASH to the future of metabolic fatty liver disease.Gut. 2021 Feb 25;70(8):1570-9. doi: 10.1136/gutjnl-2020-323202. Online ahead of print. Gut. 2021. PMID: 33632710 Free PMC article. Review.
-
Advances in the understanding and treatment of nonalcoholic fatty liver disease.Drugs. 2003;63(22):2379-94. doi: 10.2165/00003495-200363220-00001. Drugs. 2003. PMID: 14609346 Review.
-
Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence.World J Hepatol. 2022 Jan 27;14(1):168-179. doi: 10.4254/wjh.v14.i1.168. World J Hepatol. 2022. PMID: 35126846 Free PMC article. Review.